Key features of Recon4IMD

• Overall objectives: Accelerate diagnosis and personalise management of inherited metabolic diseases.

• Primary output: Clinically validated decision support tools enabling accelerated diagnosis and personalised management of inherited metabolic diseases, based on genomic, proteomic, and metabolomic data-driven computational models.

• Sustainability: Development of academic technology to meet medical regulatory standards and a roadmap for exploitation within a European foundation to aid personalised diagnosis and management of inherited metabolic diseases.

• Implemented by: A group of world-class scientists and clinicians from a diversity of disciplines who have collaborated multiple times and have a track record of leading key national and EU-funded initiatives to deliver high-impact results.

Funding

Recon4IMD is co-funded by the European Union's Horizon Europe Framework Programme (grant number 101080997), the Swiss State Secretariat for Education, Research and Innovation, and by United Kingdom Research and Innovation.

Share on Facebook Share on X Share on LinkedIn Share by WhatsApp Share by Mastodon